[
  {
    "ts": null,
    "headline": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
    "summary": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
    "url": "https://finnhub.io/api/news?id=b0934288cce7da9c2bbf2e835b824d0a6d51735a812691879b64b6565ec755fc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760127480,
      "headline": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
      "id": 137078172,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
      "url": "https://finnhub.io/api/news?id=b0934288cce7da9c2bbf2e835b824d0a6d51735a812691879b64b6565ec755fc"
    }
  },
  {
    "ts": null,
    "headline": "Abbott is a steady Medtech company in an unsteady world, says Benchmark",
    "summary": "Investing.com -- Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.",
    "url": "https://finnhub.io/api/news?id=142b77ad2e724ccfb456469038db3b5c081b02704902f13ffd6674a046ea911b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760115932,
      "headline": "Abbott is a steady Medtech company in an unsteady world, says Benchmark",
      "id": 137049057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investing.com -- Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.",
      "url": "https://finnhub.io/api/news?id=142b77ad2e724ccfb456469038db3b5c081b02704902f13ffd6674a046ea911b"
    }
  },
  {
    "ts": null,
    "headline": "Align downgraded, NetEase upgraded: Wall Street's top analyst calls",
    "summary": "Align downgraded, NetEase upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=d7bcc4456fb9ba8583985543ce0b793877272d91feaef2404568c59f51ee3dcb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760103377,
      "headline": "Align downgraded, NetEase upgraded: Wall Street's top analyst calls",
      "id": 137041610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Align downgraded, NetEase upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=d7bcc4456fb9ba8583985543ce0b793877272d91feaef2404568c59f51ee3dcb"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings",
    "summary": "Evaluate the expected performance of Abbott (ABT) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
    "url": "https://finnhub.io/api/news?id=618ab518b5a8e50144b48a76634c284c7b8c740a3b90a1fd0d3b843dc5633edd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760102103,
      "headline": "Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings",
      "id": 137041611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Evaluate the expected performance of Abbott (ABT) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
      "url": "https://finnhub.io/api/news?id=618ab518b5a8e50144b48a76634c284c7b8c740a3b90a1fd0d3b843dc5633edd"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=bd34b736839badd0e4208cafa529a64e9764453a35a7a3454ccbe545c63ad668",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760101202,
      "headline": "Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know",
      "id": 137041614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=bd34b736839badd0e4208cafa529a64e9764453a35a7a3454ccbe545c63ad668"
    }
  },
  {
    "ts": null,
    "headline": "Abbott to Report Q3 Earnings: Medical Devices Arm in Focus",
    "summary": "ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.",
    "url": "https://finnhub.io/api/news?id=8407a20195b135f215de7573f5bd6a8acefa97d287386f4ecaf547d3889da9b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760100240,
      "headline": "Abbott to Report Q3 Earnings: Medical Devices Arm in Focus",
      "id": 137041615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.",
      "url": "https://finnhub.io/api/news?id=8407a20195b135f215de7573f5bd6a8acefa97d287386f4ecaf547d3889da9b5"
    }
  },
  {
    "ts": null,
    "headline": "Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors",
    "summary": "Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) (\"Therma\" or the \"Company\"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the appointment of Michael Raimondo, a 30-year veteran in sales and operations in the healthcare industry to its Board of Directors. Michael was part of Therma's advisory Board, previously announced on August 13, 2024.Mr. Raimondo is a...",
    "url": "https://finnhub.io/api/news?id=087e2d61338e2a20770568ec8ee8e53eaf1233bda0b3f9557ccb510e338172c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760092200,
      "headline": "Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors",
      "id": 137041616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) (\"Therma\" or the \"Company\"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the appointment of Michael Raimondo, a 30-year veteran in sales and operations in the healthcare industry to its Board of Directors. Michael was part of Therma's advisory Board, previously announced on August 13, 2024.Mr. Raimondo is a...",
      "url": "https://finnhub.io/api/news?id=087e2d61338e2a20770568ec8ee8e53eaf1233bda0b3f9557ccb510e338172c1"
    }
  }
]